— Know what they know.
Not Investment Advice

NRXS AMEX

NeurAxis, Inc.
1W: -6.0% 1M: +19.5% 3M: -0.7% YTD: +59.4% 1Y: +128.6% 3Y: +74.7%
$7.11
-0.06 (-0.84%)
 
Weekly Expected Move ±13.7%
$5 $6 $7 $8 $9
AMEX · Healthcare · Biotechnology · Tech Score Strong Buy · Power 68 · $88.7M mcap · 9M float · 1.19% daily turnover · Short 51% of daily vol

Balance Sheet Trends

Total Assets
$0 -100.0% ▼
Total Liabilities
$3M +11.7% ▲
5Y CAGR: +21.3%
Shareholders Equity
$3M +64.4% ▲
5Y CAGR: +15.6%
Cash & Investments
$0 -100.0% ▼
Total Debt
$214K -54.8% ▼
5Y CAGR: -7.2%
Net Debt
$214K +106.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$321K$254K$79K$4M$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$321K$254K$79K$4M$0
Net Receivables$115K$174K$73K$245K$0
Inventory$39K$48K$21K$44K$0
Other Current Assets$0$726$70K$280K$0
Total Current Assets$491K$477K$243K$4M$0
Property, Plant & Equip.$246K$189K$159K$375K$0
Goodwill & Intangibles$24K$78K$108K$97K$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$737K$0$20K$0
Total Non-Current Assets$269K$1M$267K$491K$0
Total Assets$760K$1M$509K$5M$0
— Liabilities —
Accounts Payable$484K$2M$1M$597K$139K
Short-Term Debt$250K$489K$148K$154K$214K
Deferred Revenue$69K$59K$75K$33K$29K
Other Current Liabilities$44K$5M$342K$1M$2M
Total Current Liabilities$1M$7M$2M$2M$3M
Long-Term Debt$52K$0$0$0$0
Other Non-Current Liab.$0$0$0$0$213K
Total Non-Current Liabilities$161K$76K$27K$256K$213K
Total Liabilities$2M$7M$2M$3M$3M
— Equity —
Common Stock$3K$2K$7K$7K$11K
Retained Earnings-$29M-$34M-$49M-$57M-$65M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$826K-$6M-$1M$2M$3M
Total Liabilities & Equity$760K$1M$509K$5M$6M
— Key Metrics —
Total Debt$439K$599K$224K$473K$214K
Net Debt$118K$345K$146K-$3M$214K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms